The potential impact of pharmacogenetic testing on medication adherence
Open Access
- 3 September 2013
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 13 (6) , 481-483
Abstract
Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients’ confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.Keywords
This publication has 30 references indexed in Scilit:
- Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trialThe Pharmacogenomics Journal, 2013
- Insurance Coverage Policies for Personalized MedicineJournal of Personalized Medicine, 2012
- Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problemsPatient Education and Counseling, 2011
- Genomics and Drug ResponseNew England Journal of Medicine, 2011
- Association of age, health literacy, and medication management strategies with cardiovascular medication adherencePatient Education and Counseling, 2010
- Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene AssayJournal of Oncology Practice, 2010
- Primary Medication Non-Adherence: Analysis of 195,930 Electronic PrescriptionsJournal of General Internal Medicine, 2010
- Influence of Watchful Waiting on Satisfaction and Anxiety Among Patients Seeking Care for Unexplained ComplaintsThe Annals of Family Medicine, 2009
- Adherence to MedicationNew England Journal of Medicine, 2005
- Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settingsCochrane Database of Systematic Reviews, 2004